[
    [
        {
            "time": "",
            "orginal_text": "东吴医药行业周观点：HPV 9价疫苗8天评审通过、抗癌药物大幅减税 ，从研发评审到支付优惠 ，政策全面鼓励药品创新",
            "features": {
                "keywords": [
                    "HPV疫苗",
                    "抗癌药物",
                    "减税",
                    "政策",
                    "药品创新"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "东吴医药行业周观点：HPV 9价疫苗8天评审通过、抗癌药物大幅减税 ，从研发评审到支付优惠 ，政策全面鼓励药品创新",
            "scores": {
                "News_content": "东吴医药行业周观点：HPV 9价疫苗8天评审通过、抗癌药物大幅减税 ，从研发评审到支付优惠 ，政策全面鼓励药品创新",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "[推荐评级]医药生物行业2018年一季报和2017年业绩回顾：板块增速回升 关注优质白马及高成长个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "一季报",
                    "业绩回顾",
                    "板块增速",
                    "优质白马",
                    "高成长个股"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[推荐评级]医药生物行业2018年一季报和2017年业绩回顾：板块增速回升 关注优质白马及高成长个股",
            "scores": {
                "News_content": "[推荐评级]医药生物行业2018年一季报和2017年业绩回顾：板块增速回升 关注优质白马及高成长个股",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "[推荐评级]医药行业周报：继续看好 建议加配二线细分龙头",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "看好",
                    "二线细分龙头"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[推荐评级]医药行业周报：继续看好 建议加配二线细分龙头",
            "scores": {
                "News_content": "[推荐评级]医药行业周报：继续看好 建议加配二线细分龙头",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "只需7个一字板 药明康德市值将比肩华大基因",
            "features": {
                "keywords": [
                    "药明康德",
                    "市值",
                    "一字板",
                    "华大基因"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "只需7个一字板 药明康德市值将比肩华大基因",
            "scores": {
                "News_content": "只需7个一字板 药明康德市值将比肩华大基因",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        }
    ]
]